POPular GUILTY PILOT: Genotype-guided Clopidogrel Monotherapy
A phase 2 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 200 participants.
Also called NCT05926271
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 200 participants
- Sponsor
- Registry
-
NCT05926271
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Netherlands
- Registry status
- Recruiting
Technical summary
Registry record NCT05926271. Allocation not applicable; no masking; primary purpose treatment. Start 2023-07-15 (actual); primary completion 2026-06-15 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- POPular GUILTY PILOT: Genotype-guided Clopidogrel Monotherapy
- Acronym
- POPular GUILTY
- Condition
- Acute Coronary Syndrome
- Condition
- CYP2C19 Polymorphism
- Intervention (Drug)
- Clopidogrel
- Lead sponsor
- St. Antonius Hospital
Record details
- Record id
cardio:ct-nct05926271- Content hash
07f5f09645eafe0770e407eb0d469efbf5043d43b8d14d6d958ebd7c4d2482d6